EHR allows for reduction in blood transfusions

A Minnesota hospital has cut the average amount of blood transfused by 14 percent since 2011 using a decision support tool in its EHR.

The pathology department of Regions Hospital in St. Paul developed the tool, which is designed to improve the appropriate use of red blood cells based on the latest evidence-based clinical guidelines.

“We are successfully changing the thinking behind transfusions,” said Amar Subramanian, MD, an informatics pathologist at Regions Hospital. “A blood transfusion is like a liquid transplant, and even under ideal conditions, it’s not as good as someone’s own blood.”

As part of this work, Regions Hospital reduced the point at which doctors initiate a transfusion, called the hemoglobin trigger, to less than 7 g/dl in stable patients. The decision support tool automatically alerts physicians if a patient’s most recent hemoglobin levels are above that and also cautions against administering more than one unit of blood at a time.

Premier healthcare alliance issued a report last year analyzing blood use at 464 hospitals and determined that if all hospitals adopted these evidence-based best practices, it would result in saving more than 802,000 units of blood and $165 million without a decline in patient outcomes.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.